This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
41
A-101 Topical Solution applied Day 1, Day 15 and Day 29
Aclaris Investigational Site
Fort Washington, Pennsylvania, United States
Aclaris Investigational Site
Knoxville, Tennessee, United States
Aclaris Investigational Site
Austin, Texas, United States
Subject Satisfaction
Subject Satisfaction Questionnaire after treatment with A-101 Topical Solution
Time frame: Day 113
Effectiveness of Treatment
Effectiveness of treatment as measured by the Physician Lesion Assessment scale. The Physician Lesion Assessment Scale (PLA) is a 4 point scale used by the investigator to assess each subjects SK lesion. PLA=0 (Clear);PLA=1 (Near Clear; not elevated); PLA=2 (Thin;thickness \</= 1 mm); PLA=3 (Thick; thickness \> 1 mm).
Time frame: Day 113
Comparison of Physician Lesion Assessment Score (PLA) to Subject Satisfaction
Effectiveness of treatment assessed by PLA (4-point scale) compared to subject reported satisfaction with treatment. The PLA scale is a 4 point scale used by the investigator to assess each subject's SK lesion.
Time frame: Day 113
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.